Analysis of interleukin-10 levels in lesions of vitiligo following treatment with topical tacrolimus

British Journal of Dermatology

Volumn 161, Issue 3, 2009, Pages 654-659

  Taher, Z A ^a   Lauzon, G ^b   Maguiness, S ^b   Dytoc, M T ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Interleukin 10; Pigmentation; Protopic ; Tacrolimus; Vitiligo

Indexed keywords

INTERLEUKIN 10; TACROLIMUS;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SKIN BIOPSY; ULTRAVIOLET RADIATION; VITILIGO;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-10; MALE; MIDDLE AGED; OINTMENTS; TACROLIMUS; VITILIGO; YOUNG ADULT;

EID: 69149101044     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2009.09217.x     Document Type: Article

References (22)

1. Njoo MD, Westerhof W. Vitiligo. Pathogenesis and treatment. Am J Clin Dermatol 2001 2 : 167 181.
2. Hanifin JM, Ling MR, Langley R et al. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part I, efficacy. J Am Acad Dermatol 2001 44 : S28 38.
3. Kang S, Lucky AW, Pariser D et al. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. J Am Acad Dermatol 2001 44 : S58 64.
4. Grimes PE, Soriano T, Dytoc MT. Topical tacrolimus for repigmentation of vitiligo. J Am Acad Dermatol 2002 47 : 789 791.
5. Smith DA, Tofte SJ, Hanifin JM. Repigmentation of vitiligo with topical tacrolimus. Dermatology 2002 205 : 301 303.
6. Kanwar AS, Dogra S, Parsad D. Topical tacrolimus for treatment of childhood vitiligo in Asians. Clin Exp Dermatol 2004 29 : 589 592.
7. Lepe V, Moncada B, Castanedo-Cazares JP et al. A double-blind randomized trial of 0.1% tacrolimus vs. 0.05% clobetasol for the treatment of childhood vitiligo. Arch Dermatol 2005 139 : 581 585.
8. Silverberg NB, Lin P, Travis L et al. Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases. J Am Acad Dermatol 2004 51 : 760 766.
9. Le Poole IC, van den Wijngaard RM, Westerhof W, Das PK. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Am J Pathol 1996 148 : 1219 1228.
10. Caixia T, Hongwen F, Xiran L. Levels of soluble interleukin-2 receptor in the sera and skin tissue fluids of patients with vitiligo. J Dermatol Sci 1999 21 : 59 62.
11. Weimer R, Melk A, Daniel V et al. Switch from cyclosporine A to tacrolimus in renal transplant recipients: impact on Th1, Th2, and monokine responses. Hum Immunol 2000 61 : 884 897.
12. Muschen A, Mirmohammadsadegh A, Jarzebska-Deussen B et al. Differential IL-10 receptor gene expression in acute versus chronic atopic eczema. Modulation by immunosuppressive drugs and cytokines in normal cultured keratinocytes. Inflamm Res 1999 48 : 539 543.
13. Kostovic K, Pasic A. New treatment modalities for vitiligo. Drugs 2005 4 : 447 459.
14. Huang CL, Nordlund JJ, Boissy R. Vitiligo: a manifestation of apoptosis? Am J Clin Dermatol 2002 3 : 301 308.
15. Le Poole IC, Mutis T, van den Wijngaard RM et al. A novel, antigen-presenting function of melanocytes and its possible relationship to hypopigmentary disorders. J Immunol 1993 151 : 7284 7292.
16. Le Poole IC, van den Wijngaard RM, Westerhof W et al. Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation. J Invest Dermatol 1993 100 : 816 822.
17. Grimes PE, Morris R, Avaniss-Aghajani E et al. Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines. J Am Acad Dermatol 2004 52 : 52 61.
18. Sakuma S, Higashi Y, Sato N et al. Tacrolimus suppressed the production of cytokines involved in atopic dermatitis by direct stimulation of human PBMC system. (Comparison with steroids). Int Immunopharmacol 2001 1 : 1219 1226.
19. Kuinose M, Iwagaki H, Morimoto Y et al. Calcineurin antagonists inhibit interferon-gamma production by downregulation of interleukin-18 in human mixed lymphocyte reactions. Acta Med Okayama 2000 54 : 201 209.
20. Nagai H, Hiyama H, Matsuo A et al. FK-506 and cyclosporin A potentiate the IgE antibody production by contact sensitization with hapten in mice. J Pharmacol Exp Ther 1997 283 : 321 327.
21. Boguniewicz M, Fiedler VC, Raimer S et al. A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group. J Allergy Clin Immunol 1998 102 : 637 644.
22. Soter NA, Fleischer AB Jr., Webster GF et al. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part II, safety. J Am Acad Dermatol 2001 44 : S39 46.